Caveolin-1 expression in benign and malignant lesions of the breast
2007

Caveolin-1 Expression in Breast Cancer

Sample size: 200 publication 10 minutes Evidence: moderate

Author Information

Author(s): Liedtke Cornelia, Kersting Christian, Bürger Horst, Kiesel Ludwig, Wülfing Pia

Primary Institution: University of Münster

Hypothesis

What is the clinical relevance of Caveolin-1 in benign and malignant breast tissue?

Conclusion

Caveolin-1 is expressed in about one third of invasive breast cancers, but its expression does not correlate with survival outcomes.

Supporting Evidence

  • Caveolin-1 was not expressed in normal breast tissue or benign breast disease.
  • Caveolin-1 expression was found in 32 of 109 cases of invasive breast carcinomas.
  • No correlation was found between Caveolin-1 expression and survival parameters.

Takeaway

Caveolin-1 is a protein that can be found in some breast cancer cells, but it doesn't help doctors predict how well a patient will do.

Methodology

The study used tissue microarray technology to evaluate Caveolin-1 expression in various breast tissue samples.

Limitations

The study did not find significant correlations between Caveolin-1 expression and clinical outcomes.

Participant Demographics

The median age of patients was 59 years, with a range from 18 to 94 years.

Statistical Information

P-Value

0.008

Confidence Interval

95% CI 77–90

Statistical Significance

p=0.008

Digital Object Identifier (DOI)

10.1186/1477-7819-5-110

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication